Drugs / Tetrahydrofolate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05679050 | Oct 2022 → Oct 2024 | pancreatic exocrine neoplasm | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetrahydrofolate | “Tetrahydrofolate: 400 mg/m2 i.v.2h on D1, 15, 29” NCT05679050 ↗ |
| Modality | Small molecule | — CHEMBL2074655 ↗ |
| Route | Intravenous | “Tetrahydrofolate: 400 mg/m2 i.v.2h on D1, 15, 29” NCT05679050 ↗ |